Intismeran autogene plus pembrolizumab cut the risk of recurrence or death by 42% vs pembrolizumab alone in resected stage IIB-IV melanoma.
|Poll|August 18, 2016
Right Arm Skin Lesion Found in 47-Year-Old Man
Author(s)Cesar A. Moran, MD
A 47-year-old man presents with an “atrophic” lesion of the skin in the right arm. After a biopsy is performed, what is your diagnosis?
Advertisement
A 47-year-old man presents with an “atrophic” lesion of the skin in the right arm. Looking at the pathology slide, what is your diagnosis?
What is your diagnosis?
Advertisement
Related to this article
Cosibelimab is now a preferred, category 2A NCCN option for locally advanced CSCC when curative surgery or radiation is not feasible.
Advertisement
Advertisement
Trending on CancerNetwork
1
Intismeran Plus Pembrolizumab Reduces Recurrence Risk in Resected Melanoma
2
What Pope Leo XIV’s Lung Cancer Diagnosis Could Mean for Stigma & Nihilism
3
Zipalertinib May Introduce Another Option to EGFR Exon 20+ NSCLC
4
Rethinking Patient Selection Strategy for Phase 1 Breast Cancer Trials
5